Found 7 matching trials
Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib⢠and OPV Given at Age 2, 4, and 6 Months.
PHASE3To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Location
Multiple Locations
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants
PHASE3DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Location
Multiple Locations
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hibâ˘, Both Given Concomitantly With Oral Polio Vaccine
PHASE3The purpose of this study is to support the registration of the pentavalent...
Location
Multiple Locations
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
PHASE2This purpose of the study is to assess the safety and immunogenicity of a G...
Location
GSK Investigational Site
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
PHASE3To assess the immune memory following primary vaccination of DTPw-HBV/Hib v...
Location
GSK Investigational Site
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hibâ˘, Concomitantly With OPV in Healthy Infants
PHASE3This is a study to compare the safety and immune response of a pentavalent ...
Location
Multiple Locations
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hibâ˘
PHASE3The present trial is a follow-up of AL203 study (NCT00343889).
Primary Obj...
Location
Multiple Locations